HCWB (HCW Biologics) EPS (Basic): $-9.46 (TTM As of Mar. 2026)

What is HCW Biologics EPS (Basic)?

HCW Biologics HCWB +4.09% 39 EPS (Basic) is $-9.46 as of Mar. 2026. GuruFocus rates HCWB with a GF Score™ of 39/100 and a GF Value™ of $7.29 (Possible Value Trap). The stock has 7 warning signs investors should review.

HCW Biologics's basic earnings per share (Basic EPS) for the three months ended in Mar. 2026 was $0.37. Its basic earnings per share (Basic EPS) for the trailing twelve months (TTM) ended in Mar. 2026 was $-9.46.

HCW Biologics's EPS (Diluted) for the three months ended in Mar. 2026 was $0.37. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 was $-9.46.

HCW Biologics's EPS without NRI for the three months ended in Mar. 2026 was $0.26. Its EPS without NRIearnings per share without non-recurring items for the trailing twelve months (TTM) ended in Mar. 2026 was -9.41.

During the past 3 years, the average EPS without NRI Growth Rate was 16.80% per year. During the past 5 years, the average EPS without NRI Growth Rate was -5.10% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

During the past 7 years, HCW Biologics's highest 3-Year average EPS without NRI Growth Rate was 16.80% per year. The lowest was -51.10% per year. And the median was -7.95% per year.

HCW Biologics (NAS:HCWB) EPS (Basic) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.

HCW Biologics EPS (Basic) Related Terms

HCW Biologics EPS (Basic) Historical Data

* Premium members only.

The historical data trend for HCW Biologics's EPS (Basic) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

HCW Biologics EPS (Basic) Chart

HCW Biologics Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Dec25

EPS (Basic)

Get a 7-Day Free Trial

-27.60

-16.80

-28.00

-30.96

-10.63

HCW Biologics Quarterly Data
	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25	Jun25	Sep25	Dec25	Mar26
EPS (Basic)	Get a 7-Day Free Trial															-1.97	-6.79	-2.02	-1.02	0.37

39GF Score

HCW Biologics Inc HCWB

EPS (Basic) is just one metric. See GF Score™, valuation, warning signs, and more.

View Full Analysis

HCW Biologics EPS (Basic) Calculation

EPS (Basic) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Basic earnings per share (EPS) do not factor in the dilutive effects on convertible securities.

HCW Biologics's Basic EPS for the fiscal year that ended in Dec. 2025 is calculated as

Basic EPS (A: Dec. 2025 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Basic Average)
	=	(-7.96	-	0)	/	2.098
	=	-3.79

HCW Biologics's Basic EPS for the quarter that ended in Mar. 2026 is calculated as

Basic EPS (Q: Mar. 2026 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Basic Average)
	=	(3.472	-	0)	/	5.426
	=	0.64

EPS (Basic) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $-9.46

Frequently Asked Questions Learn more about EPS (Basic) →

What does a EPS (Basic) of $-9.46 mean?

HCW Biologics (HCWB) has a EPS (Basic) of $-9.46 as of Mar. 2026. Earnings per share (basic) equals net income divided by the standard, non-diluted average shares outstanding. View historical data on HCW Biologics and its competitors.

Is HCW Biologics' EPS (Basic) too high?

HCW Biologics' current EPS (Basic) is $-9.46. Overall, HCW Biologics has a GF Score™ of 39/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.

How does HCW Biologics' EPS (Basic) compare to MTVA and INTI?

HCW Biologics' EPS (Basic) of $-9.46 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good EPS (Basic) for a Biotechnology company?

A good EPS (Basic) depends on the Biotechnology industry context. However, EPS (Basic) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high EPS (Basic) mean?

A high EPS (Basic) can signal that a stock is expensive relative to its fundamentals. Earnings per share (basic) equals net income divided by the standard, non-diluted average shares outstanding. View historical data on HCW Biologics and its competitors. HCW Biologics's current EPS (Basic) is $-9.46. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is HCW Biologics stock overvalued right now?

Based on GuruFocus' analysis, HCW Biologics (HCWB) is currently considered Possible Value Trap. The stock's GF Value™ is $7.29, compared to a current price of $1.15 — trading 84.3% below its estimated fair value. The current EPS (Basic) is $-9.46. HCW Biologics' overall GF Score™ is 39/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is EPS (Basic) calculated?

EPS (Basic) is calculated from a company's financial statements. For HCW Biologics (HCWB), the current EPS (Basic) is $-9.46 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is HCW Biologics (HCWB) Overvalued in 2026?

Based on GuruFocus' analysis, HCW Biologics stock appears to be undervalued. The current stock price of $1.15 is trading 84.3% below its estimated GF Value™ of $7.29. GuruFocus considers HCW Biologics to be Possible Value Trap.

Key valuation signals for HCWB:

EPS (Basic): $-9.46
GF Value™: $7.29 vs. price of $1.15 (84.3% below fair value)
GF Score™: 39/100 with 7 warning signs

No single metric tells the full story. See the HCWB stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

HCW Biologics Business Description

Industry Healthcare Biotechnology

Comparable Companies MTVA INTI HOOK LNAI ICU MBRX ZEOX LEXX GDTC CYCN VRTX REGN XBRU:UCB XBRU:ARGX XKRX:207940 ALNY RVMD ASX:CSL ONC XKRX:068270

Address 2929 N. Commerce Parkway, Miramar, FL, USA, 33025

Website https://www.hcwbiologics.com

HCW Biologics Inc is a clinical-stage biopharmaceutical company developing transformative fusion immunotherapeutics to support or treat diseases promoted by chronic inflammation. It has created novel compounds that represent a new class of drugs that it believes has the potential to fundamentally change the treatment of autoimmune disorders and other proinflammatory diseases, cancer and senescence-associated dysplasia. The company has developed two proprietary drug discovery and development platforms which it uses to create novel fusion immunotherapeutics: The TOBI (Tissue factOr-Based fusIon) platform, and The T-cell Receptor Beta Chain constant region (TRBC) platform. It operates and manages its business as one reportable segment.

39GF Score

Get the complete analysis for HCWB

EPS (Basic) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$1.15

Price

$7.29

GF Value

View HCWB Analysis

See EPS (Basic) data for all stocks →